Endpoint Determination
This graph shows the total number of publications written about "Endpoint Determination" by people in the URMC Research Network by year, and whether "Endpoint Determination" was a major or minor topic of these publication.
Below are the most recent publications written about "Endpoint Determination" by people in Profiles.
-
Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011 Oct 5; 306(13):1483-4.
-
Douglas RS, Tsirbas A, Gordon M, Lee D, Khadavi N, Garneau HC, Goldberg RA, Cahill K, Dolman PJ, Elner V, Feldon S, Lucarelli M, Uddin J, Kazim M, Smith TJ, Khanna D. Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique. Arch Ophthalmol. 2009 Sep; 127(9):1155-60.
-
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
-
Brodov Y, Behar S, Goldenberg I, Boyko V, Chouraqui P. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study). Am J Cardiol. 2009 Jul 15; 104(2):194-8.
-
van Wijngaarden E, Myers GJ, Thurston SW, Shamlaye CF, Davidson PW. Interpreting epidemiological evidence in the presence of multiple endpoints: an alternative analytic approach using the 9-year follow-up of the Seychelles child development study. Int Arch Occup Environ Health. 2009 Aug; 82(8):1031-41.
-
Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain. 2008 Oct 31; 139(3):485-93.
-
Weiss B. Why methylmercury remains a conundrum 50 years after Minamata. Toxicol Sci. 2007 Jun; 97(2):223-5.
-
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007 Feb 10; 25(5):579-86.
-
Dozier A, Aligne CA, Schlabach MB. What is asthma control? Discrepancies between parents' perceptions and official definitions. J Sch Health. 2006 Aug; 76(6):215-8.
-
Wyse DG, Slee A, Epstein AE, Gersh BJ, Rocco T, Vidaillet H, Volgman A, Weiss R, Shemanski L, Greene HL. Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm. 2004 Nov; 1(5):531-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
